Detalhe da pesquisa
1.
Morphine Versus Oxycodone for Cancer Pain Using a Catechol-O-methyltransferase Genotype Biomarker: A Multicenter, Randomized, Open-Label, Phase III Clinical Trial (RELIEF Study).
Oncologist
; 28(3): 278-e166, 2023 03 17.
Artigo
em Inglês
| MEDLINE | ID: mdl-36426809
2.
Traceability Management System Using Blockchain Technology and Cost Estimation in the Metrology Field.
Sensors (Basel)
; 23(3)2023 Feb 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-36772716
3.
Clinical Application of the FoundationOne CDx Assay to Therapeutic Decision-Making for Patients with Advanced Solid Tumors.
Oncologist
; 26(4): e588-e596, 2021 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-33325566
4.
[fam-] trastuzumab deruxtecan, antitumor activity is dependent on HER2 expression level rather than on HER2 amplification.
Int J Cancer
; 145(12): 3414-3424, 2019 12 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-31087550
5.
Phase II Trial of 5-Fluorouracil, Docetaxel, and Nedaplatin (UDON) Combination Therapy for Recurrent or Metastatic Esophageal Cancer.
Oncologist
; 24(2): 163-e76, 2019 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-30361422
6.
DS-8201a, a new HER2-targeting antibody-drug conjugate incorporating a novel DNA topoisomerase I inhibitor, overcomes HER2-positive gastric cancer T-DM1 resistance.
Int J Cancer
; 141(8): 1682-1689, 2017 10 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-28677116
7.
Type 1 diabetes mellitus affected by potential toxicity from long-term use of nivolumab.
Diabetol Int
; 15(1): 130-134, 2024 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-38264226
8.
Strategic coastal dike shape for enhanced tsunami overflow reduction.
PLoS One
; 18(10): e0292930, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-37831673
9.
The impact of nutritional status in nivolumab-treated patients with advanced esophageal cancer.
PLoS One
; 18(5): e0285365, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-37146004
10.
Assessment of photodynamic therapy as a salvage treatment for local failure after chemoradiotherapy or radiotherapy for esophageal cancer in patients aged 80 years or older.
DEN Open
; 3(1): e167, 2023 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-36189170
11.
A Phase II Trial of Trifluridine/Tipiracil in Combination with Cetuximab Rechallenge in Patients with RAS Wild-Type mCRC Refractory to Prior Anti-EGFR Antibodies: WJOG8916G Trial.
Target Oncol
; 18(3): 369-381, 2023 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-37148491
12.
Novel single nucleotide polymorphism biomarkers to predict opioid effects for cancer pain.
Oncol Lett
; 26(2): 355, 2023 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-37545623
13.
Verification of flow velocity measurements using micrometer-order thermometers.
Sci Rep
; 11(1): 23778, 2021 Dec 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-34893647
14.
Pretreatment Glasgow prognostic score as a predictor of outcomes in nivolumab-treated patients with advanced gastric cancer.
PLoS One
; 16(2): e0247645, 2021.
Artigo
em Inglês
| MEDLINE | ID: mdl-33635904
15.
U3-1402 sensitizes HER3-expressing tumors to PD-1 blockade by immune activation.
J Clin Invest
; 130(1): 374-388, 2020 01 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-31661465
16.
Targeting of the HER2/HER3 signaling axis overcomes ligand-mediated resistance to trastuzumab in HER2-positive breast cancer.
Cancer Med
; 8(3): 1258-1268, 2019 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-30701699
17.
An HER3-targeting antibody-drug conjugate incorporating a DNA topoisomerase I inhibitor U3-1402 conquers EGFR tyrosine kinase inhibitor-resistant NSCLC.
Oncogene
; 38(9): 1398-1409, 2019 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-30302022
18.
B7-H3 Negatively Modulates CTL-Mediated Cancer Immunity.
Clin Cancer Res
; 24(11): 2653-2664, 2018 06 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-29530936
19.
HER2 as an Emerging Oncotarget for Colorectal Cancer Treatment After Failure of Anti-Epidermal Growth Factor Receptor Therapy.
Clin Colorectal Cancer
; 16(4): 247-251, 2017 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-28363756
20.
Clinical evaluation of palliative chemoradiotherapy for metastatic esophageal cancer.
Oncotarget
; 8(46): 80286-80294, 2017 Oct 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-29113302